Clinical/biochemical characteristics and related outcomes in people with new-onset diabetes and COVID-19: experience from a single centre

被引:5
|
作者
Munoz Moreno, Diego [1 ]
Anez Ramos, Roberto Jose [1 ]
Gonzalez Fernandez, Laura [1 ]
Rivas Montenegro, Alejandra Maricel [1 ]
Miguelez Gonzalez, Maria [2 ]
Brox Torrecilla, Noemi [3 ]
Gonzalez Albarran, Olga [1 ]
机构
[1] Gen Univ Gregorio Maranon Hosp, Endocrinol & Nutr Dept, Madrid 28009, Spain
[2] Fdn Jimenez Diaz, Endocrinol & Nutr Dept, Madrid, Spain
[3] Univ Hosp Ramon y Cajal, Endocrinol & Nutr Dept, Madrid, Spain
关键词
new-onset diabetes mellitus; COVID-19; SARS-CoV-2; hospital admission;
D O I
10.1002/pdi.2426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: It is known that there is a bidirectional relationship between diabetes mellitus (DM) and coronavirus disease (COVID-19). It has been described that those patients infected with SARS-CoV-2 could develop severe metabolic decompensation of pre-existing or new-onset DM, although diabetogenic effect of SARS-CoV-2 has still not been well consolidated. In fact, the coexistence of SARS-CoV-2 infection and new-onset DM is an infrequent situation. Methods: We describe the clinical and analytical characteristics of 19 patients admitted to a Spanish tertiary hospital - all 19 having COVID-19 infection and new-onset DM. Results: 12/19 patients (63.2%) were female; the mean age at diagnosis of DM was 54 (39-65) years. The most frequent ethnic group was Caucasian (n=9), followed by Latin-American (n=7); 7/19 (36.8%) previously met criteria for prediabetes due to altered basal glycaemia or HbA(1c). The mean BMI at diagnosis was 32.26kg/m(2) (27.62-35.18kg/m(2)). Eighteen of 19 patients (94.7%) showed bilateral bronchopneumonia. The mean blood glucose of the first blood was 17.5mmol/L (11.1-21.1mmol/L), and the mean HbA(1c) was 88mmol/mol (60-115mmol/mol). C-peptide was requested in eight patients and it was within normal range in 87.5% (n=7) and below the inferior threshold in one case. Autoantibodies were requested in 26.3% (five patients), being negative in 4/5 (80%) and positive in 1/5 (20%). Regarding the type of diabetes diagnosed, 18 were type 2 DM and only one case was diagnosed with type 1 DM. Seventeen had simple hyperglycaemia and two suffered a diabetic ketoacidosis. The mean HbA(1c) at 8.0 months (5.0-12.0 months) follow-up was 42mmol/mol (40-49mmol/mol). Conclusion: The majority of those described had type 2 DM that appears to have been unmasked by the COVID-19 infection, since they had high HbA(1c) and several risk factors for diabetes development, such as obesity and prediabetes. Most of them had their pancreatic reserve preserved, and this may suggest insulin resistance as the aetiology rather than direct beta-cell damage. A good evolution of diabetes after hospital discharge was observed in the patients followed up at our centre. Copyright (c) 2022 John Wiley & Sons.
引用
收藏
页码:24 / 31
页数:8
相关论文
共 50 条
  • [21] Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: A retrospective single centre study
    Alkundi, Alamin
    Mahmoud, Ibrahim
    Musa, Abdelmajid
    Naveed, Saima
    Alshawwaf, Mohammed
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 165
  • [22] Outcomes of Ttracheostomy in COVID-19 Patients: A Single Centre Experience
    Chandran, Aswin
    Kumar, Rajeev
    Kanodia, Anupam
    Shaphaba, Konthoujam
    Sagar, Prem
    Thakar, Alok
    INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY, 2022, 74 (SUPPL 2) : 3043 - 3049
  • [23] Outcomes of Tracheostomy in COVID-19 Patients: A Single Centre Experience
    Aswin Chandran
    Rajeev Kumar
    Anupam Kanodia
    Konthoujam Shaphaba
    Prem Sagar
    Alok Thakar
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 3043 - 3049
  • [24] Anticoagulating New-Onset Atrial Fibrillation After COVID-19: A Single-Center Experience
    Babb, Miles
    Stevenson, Kurt
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [25] Clinical characteristics of new-onset diabetes after liver transplantation and outcomes
    Shimada, Shingo
    Miyake, Katsunori
    Venkat, Deepak
    Gonzalez, Humberto
    Moonka, Dilip
    Yoshida, Atsushi
    Abouljoud, Marwan
    Nagai, Shunji
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024, 8 (03): : 383 - 393
  • [26] Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review
    Pergolizzi, Joseph
    Lequang, Jo Ann K.
    Breve, Frank
    Magnusson, Peter M.
    Varrassi, Giustino
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [27] COVID-19 in two children with new-onset diabetes: case reports
    Lanca, Ana
    Rodrigues, Claudia
    Diamantino, Catarina
    Fitas, Ana Laura
    BMJ CASE REPORTS, 2022, 15 (01)
  • [28] The COVID-19 Pandemic and New-Onset Pediatric Type 2 Diabetes
    Marks, Brynn E.
    Khilnani, Aneka
    Meyers, Abby
    Estrada, Doris E.
    Boughton, Jennifer
    Gai, Jiaxiang
    Streisand, Randi
    Monaghan, Maureen
    DIABETES, 2021, 70
  • [29] New-onset diabetes in COVID-19: An emerging threat to global health
    Sathish, Thirunavukkarasu
    INTERNATIONAL JOURNAL OF NONCOMMUNICABLE DISEASES, 2022, 7 (04) : 196 - 197
  • [30] Correction to: New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
    Anca Pantea Stoian
    Ioana-Cristina Bica
    Teodor Salmen
    Wael Al Mahmeed
    Khalid Al-Rasadi
    Kamila Al-Alawi
    Maciej Banach
    Yajnavalka Banerjee
    Antonio Ceriello
    Mustafa Cesur
    Francesco Cosentino
    Alberto Firenze
    Massimo Galia
    Su-Yen Goh
    Andrej Janez
    Sanjay Kalra
    Nitin Kapoor
    Peter Kempler
    Nader Lessan
    Paulo Lotufo
    Dimitri P. Mikhailidis
    Luigi Nibali
    Nikolaos Papanas
    Tiffany Powell-Wiley
    Ali A. Rizvi
    Amirhossein Sahebkar
    Raul D. Santos
    Peter P. Toth
    Vijay Viswanathan
    Manfredi Rizzo
    Diabetes Therapy, 2024, 15 (1) : 297 - 299